28/09/2017
Auris Medical Announces Transfer to Nasdaq Capital Market
Auris Medical Holding AG(the "Company", NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, announced today the approval of the Company's request to [...]
